Page last updated: 2024-10-21

3-methylcholanthrene and Paraneoplastic Syndromes

3-methylcholanthrene has been researched along with Paraneoplastic Syndromes in 3 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tereshchenko, IP1
Kashulina, AP1
Aleksandrova, LM1
Makino, T1
Noguchi, Y1
Ito, T1
Matsumoto, A1
von Metzler, A1
Nitsch, C1

Other Studies

3 other studies available for 3-methylcholanthrene and Paraneoplastic Syndromes

ArticleYear
[Hemocytes and the pathogenesis of malignant growth].
    Voprosy onkologii, 1983, Volume: 29, Issue:11

    Topics: Adrenocortical Hyperfunction; Animals; Erythrocyte Count; Erythrocyte Membrane; Erythrocytes, Abnorm

1983
Ultrastructural alterations of hepatocytes in the tumour-bearing, cachectic rat.
    International journal of experimental pathology, 1994, Volume: 75, Issue:6

    Topics: Animals; Body Weight; Cachexia; Endoplasmic Reticulum; Liver; Male; Methylcholanthrene; Microscopy,

1994
Carcinogenesis and the central nervous system.
    Cancer detection and prevention, 1986, Volume: 9, Issue:3-4

    Topics: Animals; Antineoplastic Agents; Brain; Brain Diseases; Central Nervous System Agents; Electroencepha

1986